Aios Medical

Accelerating the global take-up of GLP-1 medications

fellahealth.com

HQ: San Francisco, CA, USA; Remote

51-200

Healthcare

Company research

Public company, workplace, funding, and market signals

Updated Jul 30, 2026

Overview

Aios Medical (doing business as Fella Health and Bolt Pharmacy) is a San Francisco-based, founder-led consumer-health and telehealth company building ClinicOS, an AI-powered clinical operating system for direct-to-patient healthcare. It started with male-focused GLP-1 weight-loss care and now uses that stack across its own brands.

Primary product

Male-focused medication weight-loss telehealth program (Fella Health) powered by ClinicOS

Founded

2021

Headquarters

San Francisco, California, United States

Team size

51-200

Work style

Flexible

Industry

Medical Practices

Sub-industry

Telehealth / consumer health / weight-loss medicine

Business model

direct-to-consumer telehealth subscription

medication-inclusive monthly membership

clinician-guided weight-loss care

pharmacy fulfillment / medication passthrough

consumer-health software platform (ClinicOS)

Funding

Stage

seed

Total raised

$130K

Latest round

Seed · Jan 2021

Latest amount

$130K

Seed

Jan 2021 · BrandProject

$130K

People & investors

Leadership

Richie Cartwright

CEO & Co-founder

Rick Singh

VP Growth

Ben Dowdle

Head of Product

Gzim Helshani

Head of Engineering

Joy I.

Business Operations Lead

Stanley W.

Customer Success Lead

Jamie B.

Lifecycle Marketing Lead

Marjoe Bacus

Lead Designer

Dave Lane

Founding Head of Growth

Nick S.

Paid Media Lead

Founders

Luke Harries

Co-founder

Investors

AngelList Early Stage Fund

BrandProject

Founders of Indeed, Curative, Alan, Kaia Health, Vouch Insurance, and Not Boring

Global Founders Capital

Streamlined Ventures

Y Combinator

Work & culture

Founder-led, intense, and highly performance-oriented. Public hiring materials emphasize a Day 1 mentality, fast experimentation, remote/async work, and long days/weekends for senior roles.

Work style

Flexible

Compensation

Public job posts show salary-plus-equity compensation across a wide range: senior remote roles around $125k-$400k base plus equity/percent upside, UK clinical roles around £75k-£150k plus equity, and fractional clinical roles around CAD$60-$90/hour plus equity.

Benefits

board-certified clinicians

free lab work (local or at-home)

medication included in program price

free personalized health coaching

6-month money-back guarantee

HSA/FSA eligible

medication shipped to home

ongoing email check-ins

24/7 support

Product & market

Pricing

Monthly subscription / membership with medication included on some plans; some products are sold as separate monthly treatments, and UK branded-drug fulfillment is offered at cost.

Differentiators

—male-focused weight-loss brand
—GLP-1-only wedge with longitudinal care
—board-certified clinicians plus coaching plus labs
—money-back guarantee
—AI-powered ClinicOS operating layer
—medicine shipped direct to home
—US/UK multi-brand platform
—at-cost branded drug pricing in the UK

Technology

OpenAI

React

Python

TypeScript

PostgreSQL

GraphQL

Docker

Redis

dbt

Stripe

Webflow

Shopify

Mixpanel

Rudderstack

Tableau

Figma

Google Ads

Facebook Ads

GitHub

SQL

Customers

busy men seeking weight-loss treatment

men with obesity or excess bodyweight

US and UK GLP-1 patients

time-crunched consumers wanting physician-guided care

Competitors

Hims & Hers

Numan

Boots

Mochi Health

Henry Meds

Willow Health

Found

Alan Meds

Scale & contact

Estimated revenue

$250M-$500M

Estimated monthly visits

134.2K

Traffic estimate as of Jul 2026

team@joinfella.com (415) 649-5531

Signals & risks

Other

Apr 2025

Eli Lilly sued AIOS/Fella Health over compounded tirzepatide and corporate-practice-of-medicine allegations.

Source

Other

Apr 2025

FDA shortage enforcement and the end of mass compounded GLP-1 access tightened the market for Fella and peers.

Source

Acquisition

Apr 2025

AIOS acquired UK pharmacy Bolt Pharmacy and used it to reaccelerate growth after the US compounding crackdown.

Source

Latest news

Patients struggle as compounded GLP-1 access rapidly shrinks

STAT · Apr 2025

STAT described the end of mass compounded GLP-1 access after FDA shortage enforcement, a major operating shift for telehealth vendors like Fella.

Eli Lilly sues compounded Mounjaro, Zepbound providers

CNBC · Apr 2025

Lilly sued four telehealth companies including Fella Health over compounded tirzepatide, alleging deceptive marketing and unauthorized versions of its obesity drugs.

Eli Lilly opens a new legal front in its battle against compounded GLP-1s

STAT · Apr 2025

STAT reported that Lilly’s new lawsuits targeted corporate practice of medicine theories, including claims involving Fella Health.

Telehealth Start-Ups Are Marketing Weight-Loss Drugs to Men

The New York Times · Apr 2024

The New York Times covered Fella’s male-focused marketing of weight-loss drugs and the broader 'brozempic' trend.

Jobs and careers at Aios Medical

14 jobs at Aios Medical

Talent Lead at AIOS- Remote, $100-200k inc equity

Remote

Company

Remote (UK hours); Blackburn, UK

4d ago

Remote

Full-time